Programmed Death of T Cells in the Course of HIV Infection View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1995

AUTHORS

Linde Meyaard , Frank Miedema

ABSTRACT

Infection with the human immunodeficiency virus (HIV) is characterized by an asymptomatic phase of variable length and a decline in CD4+ T-cell numbers, eventually leading to the acquired immune deficiency syndrome (AIDS). Importantly, even before CD4+ T-cell numbers start to decline, functional abnormalities of T cells can be demonstrated in asymptomatically infected individuals. Both CD4+ and CD8+ T-cell function such as IL-2 production and proliferation in response to recall antigens and CD3 antibodies is affected (Shearer et al.1984; Miedema et al.1988; Schellekens et al.1990). One of the enigmas of AIDS pathogenesis is the mechanism by which HIV is capable of perturbing immune functions in a stage of infection where the number of infected cells is low (Schnittman et al.1989). In the past few years, several possible mechanisms have been investigated, including specific loss of memory cells, induction of anergy by antigen presenting cell dysfunction or dysregulation of the Thl/Th2 cytokine balance (reviewed in (Miedema et al.1994)). Following the hypothesis by Ameisen et al (Ameisen et al.1991), who proposed apoptosis as a mechanism for CD4+ T-cell depletion and loss of cellular immune function, several groups, including our group, have investigated PCD of (CD4+) T cells as a possible cause of T-cell dysfunction and CD4+ T-cell depletion in HIV-infected individuals. More... »

PAGES

115-120

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10

DOI

http://dx.doi.org/10.1007/978-1-4615-1995-9_10

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039099058

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7572385


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD4-Positive T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.417732.4", 
          "name": [
            "Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meyaard", 
        "givenName": "Linde", 
        "id": "sg:person.01321204566.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321204566.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.7177.6", 
          "name": [
            "Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miedema", 
        "givenName": "Frank", 
        "id": "sg:person.012755664317.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012755664317.02"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1995", 
    "datePublishedReg": "1995-01-01", 
    "description": "Infection with the human immunodeficiency virus (HIV) is characterized by an asymptomatic phase of variable length and a decline in CD4+ T-cell numbers, eventually leading to the acquired immune deficiency syndrome (AIDS). Importantly, even before CD4+ T-cell numbers start to decline, functional abnormalities of T cells can be demonstrated in asymptomatically infected individuals. Both CD4+ and CD8+ T-cell function such as IL-2 production and proliferation in response to recall antigens and CD3 antibodies is affected (Shearer et al.1984; Miedema et al.1988; Schellekens et al.1990). One of the enigmas of AIDS pathogenesis is the mechanism by which HIV is capable of perturbing immune functions in a stage of infection where the number of infected cells is low (Schnittman et al.1989). In the past few years, several possible mechanisms have been investigated, including specific loss of memory cells, induction of anergy by antigen presenting cell dysfunction or dysregulation of the Thl/Th2 cytokine balance (reviewed in (Miedema et al.1994)). Following the hypothesis by Ameisen et al (Ameisen et al.1991), who proposed apoptosis as a mechanism for CD4+ T-cell depletion and loss of cellular immune function, several groups, including our group, have investigated PCD of (CD4+) T cells as a possible cause of T-cell dysfunction and CD4+ T-cell depletion in HIV-infected individuals.", 
    "editor": [
      {
        "familyName": "Andrieu", 
        "givenName": "Jean-Marie", 
        "type": "Person"
      }, 
      {
        "familyName": "Lu", 
        "givenName": "Wei", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4615-1995-9_10", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4613-5823-7", 
        "978-1-4615-1995-9"
      ], 
      "name": "Cell Activation and Apoptosis in HIV Infection", 
      "type": "Book"
    }, 
    "keywords": [
      "human immunodeficiency virus", 
      "T cell numbers", 
      "T-cell depletion", 
      "T cells", 
      "immune function", 
      "cellular immune function", 
      "Th2 cytokine balance", 
      "T cell dysfunction", 
      "immune deficiency syndrome", 
      "T cell function", 
      "induction of anergy", 
      "IL-2 production", 
      "stage of infection", 
      "cytokine balance", 
      "HIV infection", 
      "immunodeficiency virus", 
      "asymptomatic phase", 
      "AIDS pathogenesis", 
      "deficiency syndrome", 
      "functional abnormalities", 
      "CD3 antibody", 
      "cell dysfunction", 
      "CD4", 
      "infection", 
      "infected cells", 
      "dysfunction", 
      "antigen", 
      "cells", 
      "specific loss", 
      "possible causes", 
      "possible mechanism", 
      "CD8", 
      "anergy", 
      "group", 
      "syndrome", 
      "pathogenesis", 
      "abnormalities", 
      "individuals", 
      "antibodies", 
      "dysregulation", 
      "memory cells", 
      "death", 
      "depletion", 
      "virus", 
      "apoptosis", 
      "proliferation", 
      "cause", 
      "induction", 
      "mechanism", 
      "loss", 
      "function", 
      "years", 
      "course", 
      "response", 
      "number", 
      "decline", 
      "enigma", 
      "hypothesis", 
      "stage", 
      "balance", 
      "length", 
      "variable length", 
      "production", 
      "PCD", 
      "et al", 
      "phase", 
      "al"
    ], 
    "name": "Programmed Death of T Cells in the Course of HIV Infection", 
    "pagination": "115-120", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039099058"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4615-1995-9_10"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7572385"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4615-1995-9_10", 
      "https://app.dimensions.ai/details/publication/pub.1039099058"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_160.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4615-1995-9_10"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-1995-9_10'


 

This table displays all metadata directly associated to this object as RDF triples.

169 TRIPLES      22 PREDICATES      99 URIs      92 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4615-1995-9_10 schema:about N0509ab73eec94768989e631bf23104cd
2 N382c9d3672d647f983f3df2057c35d5a
3 N71418cd901aa4265a39939447e51ff9c
4 N826e01321c3d498ca55b60e82b96a401
5 Nc2f0f5445d1d43779f5968586da71dfc
6 Nf835dc35b5bf4439b85f11aff2941146
7 anzsrc-for:11
8 anzsrc-for:1107
9 schema:author N7aea87f210034750bde095b917b7c7a0
10 schema:datePublished 1995
11 schema:datePublishedReg 1995-01-01
12 schema:description Infection with the human immunodeficiency virus (HIV) is characterized by an asymptomatic phase of variable length and a decline in CD4+ T-cell numbers, eventually leading to the acquired immune deficiency syndrome (AIDS). Importantly, even before CD4+ T-cell numbers start to decline, functional abnormalities of T cells can be demonstrated in asymptomatically infected individuals. Both CD4+ and CD8+ T-cell function such as IL-2 production and proliferation in response to recall antigens and CD3 antibodies is affected (Shearer et al.1984; Miedema et al.1988; Schellekens et al.1990). One of the enigmas of AIDS pathogenesis is the mechanism by which HIV is capable of perturbing immune functions in a stage of infection where the number of infected cells is low (Schnittman et al.1989). In the past few years, several possible mechanisms have been investigated, including specific loss of memory cells, induction of anergy by antigen presenting cell dysfunction or dysregulation of the Thl/Th2 cytokine balance (reviewed in (Miedema et al.1994)). Following the hypothesis by Ameisen et al (Ameisen et al.1991), who proposed apoptosis as a mechanism for CD4+ T-cell depletion and loss of cellular immune function, several groups, including our group, have investigated PCD of (CD4+) T cells as a possible cause of T-cell dysfunction and CD4+ T-cell depletion in HIV-infected individuals.
13 schema:editor Ndfbbd616aa234726a59ac80a070ba4d8
14 schema:genre chapter
15 schema:isAccessibleForFree false
16 schema:isPartOf Na1cf843c76ce45beba19224d460ed2fd
17 schema:keywords AIDS pathogenesis
18 CD3 antibody
19 CD4
20 CD8
21 HIV infection
22 IL-2 production
23 PCD
24 T cell dysfunction
25 T cell function
26 T cell numbers
27 T cells
28 T-cell depletion
29 Th2 cytokine balance
30 abnormalities
31 al
32 anergy
33 antibodies
34 antigen
35 apoptosis
36 asymptomatic phase
37 balance
38 cause
39 cell dysfunction
40 cells
41 cellular immune function
42 course
43 cytokine balance
44 death
45 decline
46 deficiency syndrome
47 depletion
48 dysfunction
49 dysregulation
50 enigma
51 et al
52 function
53 functional abnormalities
54 group
55 human immunodeficiency virus
56 hypothesis
57 immune deficiency syndrome
58 immune function
59 immunodeficiency virus
60 individuals
61 induction
62 induction of anergy
63 infected cells
64 infection
65 length
66 loss
67 mechanism
68 memory cells
69 number
70 pathogenesis
71 phase
72 possible causes
73 possible mechanism
74 production
75 proliferation
76 response
77 specific loss
78 stage
79 stage of infection
80 syndrome
81 variable length
82 virus
83 years
84 schema:name Programmed Death of T Cells in the Course of HIV Infection
85 schema:pagination 115-120
86 schema:productId N0bf8601897244993aa150066d2fedc48
87 Ne42d486fef284970938a90c2982e7f85
88 Nf1c38539d916450c8b45ed9157ce7179
89 schema:publisher N57cd9343612f4050b85668079d58c7a2
90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039099058
91 https://doi.org/10.1007/978-1-4615-1995-9_10
92 schema:sdDatePublished 2022-12-01T06:47
93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
94 schema:sdPublisher Na8885f60b1ac44c49edc222620f96e06
95 schema:url https://doi.org/10.1007/978-1-4615-1995-9_10
96 sgo:license sg:explorer/license/
97 sgo:sdDataset chapters
98 rdf:type schema:Chapter
99 N0509ab73eec94768989e631bf23104cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Apoptosis
101 rdf:type schema:DefinedTerm
102 N0bf8601897244993aa150066d2fedc48 schema:name doi
103 schema:value 10.1007/978-1-4615-1995-9_10
104 rdf:type schema:PropertyValue
105 N382c9d3672d647f983f3df2057c35d5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Lymphocyte Activation
107 rdf:type schema:DefinedTerm
108 N57cd9343612f4050b85668079d58c7a2 schema:name Springer Nature
109 rdf:type schema:Organisation
110 N5b503ad4e464426ab484318f8faf9f5f rdf:first Ned5b83fe89314b35a95bdc44ef12ddd6
111 rdf:rest rdf:nil
112 N71418cd901aa4265a39939447e51ff9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name HIV Infections
114 rdf:type schema:DefinedTerm
115 N7aea87f210034750bde095b917b7c7a0 rdf:first sg:person.01321204566.43
116 rdf:rest Nacb6d03b3e314e9187c8f6a8c4c334e5
117 N826e01321c3d498ca55b60e82b96a401 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Animals
119 rdf:type schema:DefinedTerm
120 N903a334691a5417fb0d14e5d9cb985ad schema:familyName Andrieu
121 schema:givenName Jean-Marie
122 rdf:type schema:Person
123 Na1cf843c76ce45beba19224d460ed2fd schema:isbn 978-1-4613-5823-7
124 978-1-4615-1995-9
125 schema:name Cell Activation and Apoptosis in HIV Infection
126 rdf:type schema:Book
127 Na8885f60b1ac44c49edc222620f96e06 schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 Nacb6d03b3e314e9187c8f6a8c4c334e5 rdf:first sg:person.012755664317.02
130 rdf:rest rdf:nil
131 Nc2f0f5445d1d43779f5968586da71dfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 Ndfbbd616aa234726a59ac80a070ba4d8 rdf:first N903a334691a5417fb0d14e5d9cb985ad
135 rdf:rest N5b503ad4e464426ab484318f8faf9f5f
136 Ne42d486fef284970938a90c2982e7f85 schema:name pubmed_id
137 schema:value 7572385
138 rdf:type schema:PropertyValue
139 Ned5b83fe89314b35a95bdc44ef12ddd6 schema:familyName Lu
140 schema:givenName Wei
141 rdf:type schema:Person
142 Nf1c38539d916450c8b45ed9157ce7179 schema:name dimensions_id
143 schema:value pub.1039099058
144 rdf:type schema:PropertyValue
145 Nf835dc35b5bf4439b85f11aff2941146 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name CD4-Positive T-Lymphocytes
147 rdf:type schema:DefinedTerm
148 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
149 schema:name Medical and Health Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
152 schema:name Immunology
153 rdf:type schema:DefinedTerm
154 sg:person.012755664317.02 schema:affiliation grid-institutes:grid.7177.6
155 schema:familyName Miedema
156 schema:givenName Frank
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012755664317.02
158 rdf:type schema:Person
159 sg:person.01321204566.43 schema:affiliation grid-institutes:grid.417732.4
160 schema:familyName Meyaard
161 schema:givenName Linde
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321204566.43
163 rdf:type schema:Person
164 grid-institutes:grid.417732.4 schema:alternateName Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
165 schema:name Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
166 rdf:type schema:Organization
167 grid-institutes:grid.7177.6 schema:alternateName Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
168 schema:name Department of Clinical Viro-Immunology, Laboratory for Experimental and Clinical Immunology University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
169 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...